Amanta Healthcare Limited

Amanta Healthcare Limited (AMANTA) is a micro-cap Healthcare company valued at ₹712 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Amanta Healthcare Limited last traded at ₹186.8, modestly down 0.92% on the day.

Recent developments

On 2026-06-30, the company reported its latest quarterly results, showing a net profit of ₹3 crore, which marks a decline from the ₹4 crore in the same quarter a year earlier. The promoter holding increased by 0.08 percentage points to 63.80%, indicating continued confidence in the business.

Financial performance

The company's annual revenue rose 4.6% to ₹288 crore, while annual net profit surged 48.8% to ₹15 crore. However, the latest quarter saw net profit fall 5.7% year-on-year to ₹3 crore, despite revenue growth of 5.3% to ₹69 crore.

Valuation multiples

The stock trades at 43.1 times earnings, a premium to the Healthcare median of 32.0, 3.57 times book value.

Things to watch

The company's net profit margin improved to 5.2% from 3.6% in the prior year, but the latest quarter's net profit declined. The stock is 9.3% below its 52-week high, and the company has not paid any dividends despite reporting profits.

Where it stands

Amanta Healthcare Limited ended the latest quarter with revenue of ₹69 crore and net profit of ₹3 crore, showing a slight decline in profitability compared to the same quarter a year ago. The company's promoter holding increased slightly, but its stock remains below its 52-week high.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.